Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Benaglutide for weight control in overweight/obese adults
CTR20190408Phase 3Completed
- Sponsor
- Shanghai Renhui Biopharmaceutical
- Start
- Apr 2019
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of beinaglutide in obesity, Overweight, sponsored by Shanghai Renhui Biopharmaceutical. Started Apr 2019; status: completed.
02
Drugs
beinaglutide
03
Conditions
obesityOverweight
Beyond the preview
Go deeper on CTR20190408.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20190408.